Dublin, April 29, 2025 (GLOBE NEWSWIRE) -- The "High Intensity Focused Ultrasound - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for High Intensity Focused Ultrasound (HIFU) is expected to expand from an estimated US$1.3 billion in 2024 to US$1.8 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.3%. This in-depth analysis sheds light on market dynamics, trends, and forecasts, providing essential insights for informed business decisions. Noteworthy are the latest global tariff developments impacting the HIFU market.
This technology is gaining popularity, particularly in oncology, for its ability to destroy localized tumors while preserving healthy tissue. Emerging research on its neurotherapeutic applications is expanding its utility to treat brain disorders such as Parkinson's disease. Integration with advanced imaging enhances precision, making HIFU a preferred choice in clinical settings. In cosmetic dermatology, it sees growing use in skin tightening and body contouring, further enhancing its market potential.
Beyond oncology, HIFU is finding applications in regenerative medicine, pain management, and targeted drug delivery. In cardiovascular treatments, its potential for addressing arrhythmias and arterial plaque removal marks a novel non-invasive approach. Orthopedic applications include non-surgical osteoarthritis treatment and accelerated bone healing through tissue stimulation. HIFU is also being explored for stem cell proliferation and differentiation in regenerative medicine. Neuromodulation is another promising field, with research indicating its potential in treating depression and chronic pain. Its use in veterinary medicine for tumor treatment further highlights its versatility.
Technological advancements are propelling HIFU forward. Real-time imaging such as MRI and ultrasound-guided treatments enhance accuracy and safety. Innovations in transducer technology and AI-driven treatment planning are optimizing therapeutic outcomes. The development of portable and affordable HIFU devices is increasing accessibility, particularly in outpatient and emerging markets. Additionally, research into HIFU-assisted drug delivery is opening new therapeutic frontiers.
The HIFU market is driven by rising demand for non-invasive procedures, increasing cases of cancer and chronic diseases, and ongoing technological advancements. Outpatient care preference boosts HIFU adoption, offering effective surgical alternatives without hospital stays. Aging populations and regulatory support are also key growth factors. Expansion in private healthcare and increased affordability in emerging economies present new market opportunities.
Report Highlights:
- Segments include detection for uterine fibroids, prostate cancer, and more. End-use sectors are hospitals and imaging centers.
- Geographic scope covers the U.S., China, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Significant growth in the Uterine Fibroids Detection segment, projected at US$521.6 million by 2030. Prostate Cancer Detection is also on a growth path.
- Regional focus: U.S. market at $346.3 million in 2024, China to grow at 10.3% CAGR, reaching $383.8 million by 2030.
Key Competitors: Alpinion Medical Systems Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., EDAP TMS, FUJIFILM VisualSonics Inc., and more. Total of 32 featured companies.
This edition includes a detailed tariff impact analysis, incorporating insights from over 180 countries and exploring the global supply chain and competitiveness landscape. Buyers will receive updated forecasts and strategic insights into geographic shifts in sourcing and trade exposure, with a free update in July 2025.
A selection of companies mentioned in this report includes, but is not limited to:
- Alpinion Medical Systems Co. Ltd.
- Chongqing Haifu Medical Technology Co. Ltd.
- EDAP TMS
- FUJIFILM VisualSonics Inc.
- FUS Instruments
- Insightec Ltd.
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Medtronic PLC
- Mianyang Sonic Electronic Ltd.
- Profound Medical Corp.
- Shanghai A&S Co. Ltd.
- Sofwave Medical Ltd.
- Sonablate Corp.
- SonaCare Medical, LLC
- Stryker Corporation
- SuperSonic Imagine
- Theraclion
- Ultrasound Technologies Ltd.
- Verasonics, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/6hxurp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
